Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
Recruiting now · Not applicable
Conditions studied: Rectal Cancer, Head and Neck Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Oligometastasis, Esophageal Cancer
In brief
This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.
Key facts
- Study ID
- NCT04172753
- Run by
- University Hospital Tuebingen
- People needed
- 472
- Starts
- 2018-05-09
- Expected to finish
- 2027-05-09
- Last updated by the study team
- 2019-11-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- existing indication for radiation therapy
- minimum age 18 years, no upper age limit
- capacity for consent
- Informed consent
You may not qualify if…
- contraindication for MRI (claustrophobia, metallic implants not applicable for MRI
- pregnancy
Where it is running
- University Hospital Tübingen, Department of Radiation Oncology — Tübingen, Baden-Wurttemberg, Germany (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.